Multiple blockbusters from Gilead, Pfizer, Vertex see (list) price hikes to start 2022

Kicking off 2022, hundreds of pharmaceuticals, including some blockbusters, saw their list prices rise by about 5% on average. But overall, net drug prices (cost after rebates) declined for the fourth year in a row, potentially complicating already stalled drug price reform efforts.

Among the drugs seeing new increases as...

Click to view original post